Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients’ blood is a research paper published in npj Systems Biology and Applications (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P30-CA033572
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
Grant: U01-CA232216
NCI NIH HHS
Grant: U01 CA232216
NIAID NIH HHS
Grant: U19 AI172713
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Grant: U19-AI172713
NCI NIH HHS
Grant: P30 CA033572
NLM NIH HHS
Grant: R01 LM013876
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
National Institutes of Health
Grant: 5U01CA232216-05
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer
U.S. Department of Health & Human Services | NIH | National Cancer Institute
FWCI
0.31
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals